In a hypothermic patient presenting with ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT), should treatment prioritize rapid core re‑warming after the initial defibrillation shock?

Treatment of VF/VT in Hypothermic Patients: Prioritize Controlled Rewarming Over Rapid Rewarming

In hypothermic patients with VF or VT, treatment should NOT aim for rapid core rewarming; instead, controlled rewarming at rates <5°C/hour (ideally 1.5-4°C/hour) should be the goal, as rapid rewarming significantly worsens neurological outcomes and mortality. 1

The Critical Evidence Against Rapid Rewarming

The 2025 AHA Guidelines provide definitive evidence that rewarming rates >5°C/hour are associated with significantly worse outcomes. Specifically:

• Rewarming rates <5°C/hour showed **2.41 greater odds of neurologically intact survival** compared to rates >5°C/hour 1
• Neurologically intact survival decreased by 1.9% for each 1°C/hour increase in rewarming rate 1
• Optimal rewarming rates are between 1.5-4°C/hour 1

The mechanism is clear: rapid rewarming causes relative cerebral hyperthermia, potentially worsening neurological outcomes, while slow rewarming may delay organ perfusion but ultimately provides better survival 1.

The Treatment Algorithm for Hypothermic VF/VT

Initial Defibrillation Approach

Attempt defibrillation BEFORE rewarming, but with specific limitations:

• Defibrillate once initially at presentation 1
• If VF/VT persists, defer additional defibrillation attempts until core temperature reaches 30°C (86°F) 1
• The Wilderness Medical Society recommends this single-shock approach, while ERC guidelines allow up to 3 attempts before reaching 30°C 1

Critical caveat: The hypothermic heart is less responsive to defibrillation below 30°C, and excessive defibrillation attempts cause myocardial injury 1. While defibrillation before rewarming CAN be successful 1, success rates improve dramatically once temperature reaches 30°C 1.

Rewarming Method Selection

ECMO (extracorporeal membrane oxygenation) is the preferred rewarming method for hypothermic cardiac arrest:

• ECMO shows 41% greater probability of survival compared to cardiopulmonary bypass 1
• Multiple retrospective studies demonstrate survival benefit and improved neurological outcomes with ECLS over conventional CPR 1
• Transport to ECLS-capable centers improves neurologically favorable outcomes and 1-month survival 1

During Rewarming: The Controlled Approach

Set ECMO/ECLS rewarming rate at 1.5-4°C/hour, NOT faster:

1. Begin controlled rewarming immediately upon ECLS initiation
2. Monitor core temperature continuously
3. At 30°C (86°F): Resume defibrillation attempts if VF/VT persists
4. Continue controlled rewarming until normothermia achieved

Common Pitfalls to Avoid

Pitfall #1: Attempting rapid rewarming to "quickly restore normal physiology"

• This intuitive approach is wrong and kills patients through cerebral hyperthermia 1

Pitfall #2: Repeated defibrillation attempts below 30°C

• This causes myocardial injury without benefit, as the cold myocardium is unresponsive 1
• Large observational studies show increasing defibrillation attempts do NOT improve outcomes 1

Pitfall #3: Using conventional rewarming methods when ECLS is available

• Conventional methods are slower and associated with worse outcomes 1
• Surface rewarming averages only 2.4°C/hour 2

Medication Considerations During Hypothermia

The hypothermic heart may be less responsive to epinephrine, and slowed metabolism raises concerns for drug accumulation and toxicity 1. However, some cases show normal responses to epinephrine before rewarming 1. The optimal temperature for first epinephrine administration remains unstudied 1.

Prognostic Factors

Use validated scoring systems to guide decision-making:

• HOPE score <0.1 predicts mortality in adults on ECLS 1
• ICE survival score >12 predicts survival in adults and children 1

These are better validated than individual factors like potassium, lactate, or pH 1.